Clinical Trial Update: HIV-1 Vaccine Test in Uninfected Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 HIV-1 vaccine study in healthy, HIV seronegative adults completed, sponsored by NIAID.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• HIV-1 vaccine (NIAID trial)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Healthy, HIV Seronegativity | Phase 1 | Status: COMPLETED